From Variability to Standardization: The Impact of Breast Density on Background Parenchymal Enhancement in Contrast-Enhanced Mammography and the Need for a Structured Reporting System
Launched by GRAZIELLA DI GREZIA · Feb 15, 2025
Trial Information
Current as of September 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients who underwent CEM, mammography, and ultrasound between May 2022 and June 2023.
- • Availability of BPE assessment and BI-RADS density classification.
- • Complete imaging dataset available for analysis.
- Exclusion Criteria:
- • Patients with prior breast cancer treatment that could alter BPE.
- • Incomplete imaging data or missing classification values.
- • Contraindications to contrast-enhanced imaging.
About Graziella Di Grezia
Graziella Di Grezia is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on integrity and ethical standards, the organization collaborates with healthcare professionals and institutions to conduct rigorous trials across various therapeutic areas. Graziella Di Grezia prioritizes patient safety and data integrity, leveraging cutting-edge methodologies and comprehensive monitoring to ensure the highest quality of clinical research. Their mission is to contribute to the development of effective treatments and enhance the understanding of medical conditions, ultimately benefiting patients and the broader healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brindisi, Italy
Patients applied
Trial Officials
Graziella Di Grezia, Medicine and Surgery
Principal Investigator
Link Campus University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported